title: Indications and limitations of vismodegib for basal cell carcinoma.
authors.affiliation: Orbital Oncology and Ophthalmic Plastic Surgery Program, Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston.
authors.forename: Vivian T
authors.initials: VT
authors.lastname: Yin
authors.affiliation: Orbital Oncology and Ophthalmic Plastic Surgery Program, Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston.
authors.forename: Matthew
authors.initials: M
authors.lastname: Sniegowski
authors.affiliation: Orbital Oncology and Ophthalmic Plastic Surgery Program, Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston.
authors.forename: Bita
authors.initials: B
authors.lastname: Esmaeli
mesh_terms: D000813:Anilides / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002280:Basal Cell Carcinoma / Q000188:drug therapy*; D005142:Eyelid Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D009918:Orbital Neoplasms / Q000188:drug therapy*; D011725:Pyridines / Q000627:therapeutic use*; D012878:Skin Neoplasms / Q000188:drug therapy*
chemical_list: D000813:Anilides; D000970:Antineoplastic Agents; D011725:Pyridines